JOINT FILING AGREEMENT

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that Amendment No. 6 to the Statement on Schedule 13D, dated February 16, 2024, with respect to the common stock of Kinnate Biopharma Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 21st day of February 2024.

	ORBIMED ADVISORS LLC
	By:	/s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Member
	ORBIMED ASIA XX XX, L.P.
	By:	ORBIMED ADVISORS IV LIMITED, its general partner
	By:	/s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Director of OrbiMed Advisors IV Limited
	ORBIMED ADVISORS IV LIMITED
	By:	/s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Director
	ORBIMED CAPITAL GP VII LLC
	By:	ORBIMED ADVISORS LLC, its managing member
	By:	s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Member of OrbiMed Advisors LLC
	ORBIMED GENESIS GP LLC
	By:	ORBIMED ADVISORS LLC, it’s managing member
	By:	/s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Member of OrbiMed Advisors LLC

	ORBIMED CAPITAL LLC
	By:	/s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Member
	ORBIMED CAPITAL GP VIII LLC
	By:	ORBIMED ADVISORS LLC, its managing member
	By:	s/ Xxxx X. Xxxxxx
		Name: Xxxx X. Xxxxxx
		Title: Member of OrbiMed Advisors LLC